EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  5. Coronavirus-Patienten dürfen unter Auflagen mit Remdesivir behandelt werden, Symbolfotos

Coronavirus-Patienten dürfen unter Auflagen mit Remdesivir behandelt werden, Symbolfotos

25.06.2020

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909648x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909648x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909644x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909644x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909642x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909642x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909641x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909641x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909635x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909635x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909633x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of a vaccine for COVID-19 (new coronavirus) in a laboratory environment. x1909633x CaduxRolim

  • 01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

    01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

  • 01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

    01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

  • 01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

    01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

  • A building on the Gilead campus in Foster City, California is seen on Thursday, April 23, 2020. Data on Gilead s antiviral medicine remdesivir from a clinical trial in China, suggest it failed to speed the improvement of patients with Covid-19. Gilead, however, said the data, released by accident, suggest a potential benefit. SXP2020042314 TERRYxSCHMITT

    A building on the Gilead campus in Foster City, California is seen on Thursday, April 23, 2020. Data on Gilead s antiviral medicine remdesivir from a clinical trial in China, suggest it failed to speed the improvement of patients with Covid-19. Gilead, however, said the data, released by accident, suggest a potential benefit. SXP2020042314 TERRYxSCHMITT

Kollektionen
Auswahl